Company Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 22,959 18,782 13,803 7,625 7,383 6,224 - -
Change - -18.19% -26.51% -44.76% -3.16% -15.71% - -
Enterprise Value (EV) 1 21,903 16,608 11,574 5,707 6,451 4,985 4,800 4,432
Change - -24.17% -30.31% -50.69% 13.04% -22.73% -3.71% -7.66%
P/E 24.7x 18.6x 25.2x 67.6x 28.1x 13.8x 11.6x 9.59x
PBR 3.49x 2.53x 1.78x 1.02x 1.03x 0.84x 0.81x 0.77x
PEG - 2.14x -0.6x -0.9x 0x 0.2x 0.6x 0.5x
Capitalization / Revenue 1.57x 1.08x 0.79x 0.42x 0.43x 0.35x 0.33x 0.31x
EV / Revenue 1.5x 0.95x 0.67x 0.32x 0.37x 0.28x 0.26x 0.22x
EV / EBITDA 16.9x 11x 10.6x 3.13x 9x 2.66x 2.28x 1.84x
EV / EBIT 20.5x 13.4x 11.8x 20.5x 15.3x 6.81x 5.69x 4.44x
EV / FCF - - 6.14x 3.89x 4.76x 4.53x 3.18x 2.36x
FCF Yield - - 16.3% 25.7% 21% 22.1% 31.5% 42.5%
Dividend per Share 2 0.3 0.4 0.4 0.3 0.2 0.3607 0.4926 0.6117
Rate of return 0.78% 1.27% 1.73% 2.3% 1.56% 3.33% 4.54% 5.64%
EPS 2 1.561 1.697 0.9206 0.1927 0.4571 0.7851 0.9351 1.13
Distribution rate 19.2% 23.6% 43.4% 156% 43.8% 45.9% 52.7% 54.1%
Net sales 1 14,585 17,432 17,380 18,000 17,336 17,571 18,586 19,934
EBITDA 1 1,295 1,511 1,087 1,823 716.6 1,874 2,101 2,411
EBIT 1 1,066 1,243 982.9 278 422.4 731.7 844 997.9
Net income 1 921.5 1,010 549.4 114.1 263.4 456.2 546.7 663.5
Net Debt 1 -1,056 -2,174 -2,229 -1,917 -932 -1,239 -1,424 -1,791
Reference price 2 38.51 31.51 23.16 13.02 12.86 10.84 10.84 10.84
Nbr of stocks (in thousands) 596,181 596,071 596,005 585,604 574,128 574,128 - -
Announcement Date 3/14/22 3/17/23 3/19/24 4/27/25 4/28/26 - - -
1CNY in Million2CNY
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
13.67x0.28x2.63x3.36% 919M
15.81x0.61x9.1x-.--% 14.11B
16.54x0.74x7.74x2.25% 6.45B
19.56x0.72x12.19x1.28% 6.07B
14.65x0.9x6.28x2.89% 4.11B
14.19x1.22x7.46x5.7% 3.14B
14.05x0.59x4.57x5.14% 3.11B
36.7x - - - 2.85B
14.32x0.86x6.44x4.54% 2.97B
Average 17.72x 0.74x 7.05x 3.15% 4.86B
Weighted average by Cap. 17.30x 0.73x 8.25x 2.07%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. 002727 Stock
  4. Valuation Yixintang Pharmaceutical Group Co., Ltd.
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!